MedTrace Logo

CardioSecur Connected Electrocardiography in General Care

NCT03351660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 338

Last updated 2022-04-12

No results posted yet for this study

Summary

Heart disease symptoms are a frequent reason of consultation in general medical practice. Only a few general practitioners are equipped with a 12 lead Electrocardiography (ECG) whereas this test is extremely useful for diagnosis orientation in cases of cardiac diseases.Cardiosecur allows the realization of a 15 or 22 leads ECG with only 4 electrodes connected to a smartphone or a tablet with an automatic interpretation function. The goal of the study is to evaluate the diagnostic value of Cardiosecur device regarding cardiac symptoms in family practice.

Conditions

  • Heart Diseases
  • Connected ECG
  • Family Practice

Interventions

DIAGNOSTIC_TEST

connected ECG

Cardiosecur allows the realization of a 15 or 22 leads ECG with only 4 electrodes connected to a tablet with an automatic interpretation function

Sponsors & Collaborators

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Aymeric Menet, MD · Groupement des Hôpitaux de l'Institut Catholique de Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-15
Primary Completion
2019-03-28
Completion
2019-03-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03351660 on ClinicalTrials.gov